Multiple sclerosis in men: management considerations

Multiple sclerosis (MS) is a lifelong disease typically affecting individuals in young to middle adulthood. There are recognized sex differences in MS onset and clinical course. MS affects approximately three times more women than men, thus resulting in less attention to the male experience (i.e. diagnosis, management, societal dimensions). Here, we review current scientific evidence on sex differences in MS risk and course, highlight potential sources of bias, and suggest avenues of further inquiry. We then describe what is known about male experiences with MS diagnosis, treatment, and symptom management (particularly mood and sexual function). Finally, we consider ways in which healthcare providers might engage male patients in the broader aspects of living with MS (e.g. familial and societal relationships) to influence their long-term quality of life (QOL). When possible, we draw from published sources to underscore our collective clinical and scientific experiences.

[1]  F. Foley,et al.  Alcohol and substance use in multiple sclerosis , 2014, Journal of the Neurological Sciences.

[2]  N. Carlson Psychology: The Science of Behavior , 1987 .

[3]  M. McCabe Exacerbation of Symptoms Among People with Multiple Sclerosis: Impact on Sexuality and Relationships over Time , 2004, Archives of sexual behavior.

[4]  V. Tomassini,et al.  ‘Gender gap’ in multiple sclerosis: magnetic resonance imaging evidence , 2003, European journal of neurology.

[5]  A. Serretti,et al.  Clinical and genetic factors associated with suicide in mood disorder patients , 2016, European Archives of Psychiatry and Clinical Neuroscience.

[6]  L. Berkman,et al.  Relation of social integration to inflammatory marker concentrations in men and women 70 to 79 years. , 2006, The American journal of cardiology.

[7]  Lisbet Nyström,et al.  Unemployment and Health , 2015, American journal of men's health.

[8]  P. Groenewegen,et al.  Do everyday problems of people with chronic illness interfere with their disease management? , 2015, BMC Public Health.

[9]  G. Koren,et al.  Management of Multiple Sclerosis During Pregnancy and the Reproductive Years , 2014 .

[10]  J L Haines,et al.  Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis , 2004, Neurology.

[11]  Deborah M. Miller,et al.  Evidence-based guideline: Assessment and management of psychiatric disorders in individuals with MS , 2014, Neurology.

[12]  N. Baxter,et al.  Injectable Disease-Modifying Therapy for Relapsing-Remitting Multiple Sclerosis: A Review of Adherence Data , 2010, The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses.

[13]  A. Kennedy,et al.  The Contribution of Social Networks to the Health and Self-Management of Patients with Long-Term Conditions: A Longitudinal Study , 2014, PloS one.

[14]  Olga V. Demler,et al.  Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. , 2005, Archives of general psychiatry.

[15]  R. Gold,et al.  Parenthood and immunomodulation in patients with multiple sclerosis , 2010, Journal of Neurology.

[16]  T. J. Murray,et al.  Short Term Predictors of Unemployment in Multiple Sclerosis Patients , 2003, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[17]  F. Baum,et al.  The interplay between structure and agency in shaping the mental health consequences of job loss , 2013, BMC Public Health.

[18]  K. Hyllested,et al.  Suicide and multiple sclerosis: an epidemiological investigation. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[19]  R. Mehran,et al.  Gender differences in outcomes in patients with acute coronary syndrome in the current era: A review , 2016, European heart journal. Acute cardiovascular care.

[20]  Leah P. Dickstein,et al.  Thoughts of death and self-harm in patients with epilepsy or multiple sclerosis in a tertiary care center. , 2015, Psychosomatics.

[21]  R. Elashoff,et al.  Testosterone treatment in multiple sclerosis: a pilot study. , 2007, Archives of neurology.

[22]  F. Foley,et al.  Depression levels and interferon treatment in people with multiple sclerosis. , 2012, International journal of MS care.

[23]  J. Castelli-Haley,et al.  The Impact of Comorbid Depression on Adherence to Therapy for Multiple Sclerosis , 2011, Multiple sclerosis international.

[24]  J. Robbins,et al.  Gender differences in the utilization of health care services. , 2000, The Journal of family practice.

[25]  Mohammed Azmi Al-Betar,et al.  comprehensive review : Krill Herd algorithm ( KH ) and its pplications saju , 2016 .

[26]  T. Chitnis,et al.  The role of gender and sex hormones in determining the onset and outcome of multiple sclerosis , 2014, Multiple sclerosis.

[27]  D. Paty,et al.  Cause of death in patients attending multiple sclerosis clinics , 1991, Neurology.

[28]  B. Kieseier,et al.  Pregnancy Outcomes Following Maternal and Paternal Exposure to Teriflunomide During Treatment for Relapsing–Remitting Multiple Sclerosis , 2014, Neurology and Therapy.

[29]  D. Paty,et al.  Disability progression in multiple sclerosis is slower than previously reported , 2006, Neurology.

[30]  C. Wegner,et al.  Gender differences in the histopathology of MS? , 2009, Journal of the Neurological Sciences.

[31]  D. Campagnolo,et al.  Treatment discontinuation and disease progression with injectable disease-modifying therapies: findings from the north american research committee on multiple sclerosis database. , 2013, International journal of MS care.

[32]  J. Wolinsky,et al.  Glatiramer acetate treatment in PPMS: Why males appear to respond favorably , 2009, Journal of the Neurological Sciences.

[33]  R. Marrie,et al.  The impact of sexual dysfunction on health-related quality of life in people with multiple sclerosis , 2014, Multiple sclerosis.

[34]  Ariel Miller,et al.  Health-related Quality of Life in Multiple Sclerosis: The Impact of Disability, Gender and Employment Status , 2006, Quality of Life Research.

[35]  M. Çebi,et al.  Epigenetics of Multiple Sclerosis: An Updated Review , 2014, NeuroMolecular Medicine.

[36]  W. Valdar,et al.  Sex ratio of multiple sclerosis in Canada: a longitudinal study , 2006, The Lancet Neurology.

[37]  Christina Wolfson,et al.  High incidence and increasing prevalence of multiple sclerosis in British Columbia, Canada: findings from over two decades (1991–2010) , 2015, Journal of Neurology.

[38]  J. Haselkorn,et al.  The Gulf War era multiple sclerosis cohort: age and incidence rates by race, sex and service. , 2012, Brain : a journal of neurology.

[39]  D. Centonze,et al.  Quality of life, depression and fatigue in mildly disabled patients with relapsing–remitting multiple sclerosis receiving subcutaneous interferon beta-1a: 3-year results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study , 2011, Multiple sclerosis.

[40]  M. Bottai,et al.  Modest familial risks for multiple sclerosis: a registry-based study of the population of Sweden , 2014, Brain : a journal of neurology.

[41]  B. Weinstock-Guttman,et al.  Impact of diagnosis and early treatment on the course of multiple sclerosis. , 2013, The American journal of managed care.

[42]  L. Berkman,et al.  Social ties and mental health , 2001, Journal of Urban Health.

[43]  Gary M Owens,et al.  Gender Differences in Health Care Expenditures, Resource Utilization, and Quality of Care , 2008, Journal of managed care pharmacy : JMCP.

[44]  A. Filouš [Diagnosis of multiple sclerosis]. , 1989, Ceskoslovenska neurologie a neurochirurgie.

[45]  Yinshan Zhao,et al.  Relative mortality and survival in multiple sclerosis: findings from British Columbia, Canada , 2011, Journal of Neurology, Neurosurgery & Psychiatry.

[46]  M. Schwartz,et al.  Therapy Optimization in Multiple Sclerosis: a cohort study of therapy adherence and risk of relapse. , 2015, Multiple sclerosis and related disorders.

[47]  B. Weinshenker,et al.  Natural history of multiple sclerosis. , 2005, Neurologic clinics.

[48]  S. Kirzinger,et al.  Relationship between disease-modifying therapy and depression in multiple sclerosis. , 2013, International journal of MS care.

[49]  Pierre Grammond,et al.  Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS , 2015, PloS one.

[50]  M. McCabe Relationship functioning and sexuality among people with multiple sclerosis , 2002, Journal of sex research.

[51]  J. Bell,et al.  Parental transmission of HLA-DRB1*15 in multiple sclerosis , 2007, Human Genetics.

[52]  P. Mccombe,et al.  Female reproductive issues in multiple sclerosis , 2013, Multiple sclerosis.

[53]  M. Pompili,et al.  Suicide risk in multiple sclerosis: a systematic review of current literature. , 2012, Journal of psychosomatic research.

[54]  M. Glymour,et al.  Social Ties and Cognitive Recovery after Stroke: Does Social Integration Promote Cognitive Resilience? , 2008, Neuroepidemiology.

[55]  R. Mutani,et al.  Fertility in patients with multiple sclerosis: current knowledge and future perspectives , 2006, Neurological Sciences.

[56]  C. Koebnick,et al.  Childhood obesity and risk of pediatric multiple sclerosis and clinically isolated syndrome , 2013, Neurology.

[57]  T. Chitnis,et al.  Body size and risk of MS in two cohorts of US women , 2009, Neurology.

[58]  A. Minagar,et al.  Increasing female preponderance of multiple sclerosis in Isfahan, Iran: a population-based study , 2010, Multiple sclerosis.

[59]  K. Joseph,et al.  Impact of parental multiple sclerosis on early childhood development: A retrospective cohort study , 2015, Multiple sclerosis.

[60]  A. Döring,et al.  Expert recommendations to personalization of medical approaches in treatment of multiple sclerosis: an overview of family planning and pregnancy , 2012, EPMA Journal.

[61]  C. Guttmann,et al.  No sex-specific difference in disease trajectory in multiple sclerosis patients before and after age 50 , 2013, BMC Neurology.

[62]  J. Lechner-Scott,et al.  The Australian Multiple Sclerosis (MS) Immunotherapy Study: A Prospective, Multicentre Study of Drug Utilisation Using the MSBase Platform , 2013, PloS one.

[63]  C. Wolfson,et al.  Reduced duration of breastfeeding is associated with a higher risk of multiple sclerosis in both Italian and Norwegian adult males: the EnvIMS study , 2015, Journal of Neurology.

[64]  W. Valdar,et al.  Association of Infectious Mononucleosis with Multiple Sclerosis , 2009, Neuroepidemiology.

[65]  C. Tench,et al.  Mortality in multiple sclerosis: meta-analysis of standardised mortality ratios , 2015, Journal of Neurology, Neurosurgery & Psychiatry.

[66]  H. Tremlett,et al.  Interrupted therapy , 2003, Neurology.

[67]  T. Chitnis,et al.  Low testosterone is associated with disability in men with multiple sclerosis , 2014, Multiple sclerosis.

[68]  W. Kozubski,et al.  Quality of life and social support in patients with multiple sclerosis. , 2010, Neurologia i neurochirurgia polska.

[69]  P. Mccombe,et al.  Gender differences in autoimmune disease , 2014, Frontiers in Neuroendocrinology.

[70]  E. McDonald,et al.  Living with multiple sclerosis: longitudinal changes in employment and the importance of symptom management , 2010, Journal of Neurology.

[71]  M. Ramanathan,et al.  Increased tissue damage and lesion volumes in African Americans with multiple sclerosis , 2010, Neurology.

[72]  M. Stokes,et al.  Changes in quality of life and coping among people with multiple sclerosis over a 2 year period , 2009, Psychology, health & medicine.

[73]  G. Kraft,et al.  The role of spouse responses to disability and family environment in multiple sclerosis. , 1999, American journal of physical medicine & rehabilitation.

[74]  Nancy Xiaonan Yu,et al.  Effect of comorbidity on mortality in multiple sclerosis , 2015, Neurology.

[75]  H. Harbo,et al.  Sex and age at diagnosis are correlated with the HLA-DR2, DQ6 haplotype in multiple sclerosis , 2000, Journal of the Neurological Sciences.

[76]  A. Compston,et al.  The natural history of multiple sclerosis , 2006, McAlpine's Multiple Sclerosis.

[77]  L. Kappos,et al.  Gender effects on intramuscular interferon beta-1a in relapsing–remitting multiple sclerosis: analysis of 1406 patients , 2011, Multiple sclerosis.

[78]  W. Beardslee,et al.  Children of affectively ill parents: a review of the past 10 years. , 1998, Journal of the American Academy of Child and Adolescent Psychiatry.

[79]  D. Mohr,et al.  Self-Injection Anxiety Training: a treatment for patients unable to self-inject injectable medications , 2005, Multiple sclerosis.

[80]  A. Feinstein,et al.  In multiple sclerosis anxiety, not depression, is related to gender , 2016, Multiple sclerosis.

[81]  J. Castelli-Haley,et al.  Cost sharing, benefit design, and adherence: the case of multiple sclerosis. , 2010, Advances in health economics and health services research.

[82]  S. Reingold,et al.  Risk evaluation and monitoring in multiple sclerosis therapeutics , 2014, Multiple sclerosis.

[83]  M. Gunnarssona,et al.  Characteristics in childhood and adolescence associated with future multiple sclerosis risk in men : cohort study , 2015 .

[84]  D. Goodin,et al.  Mortality in patients with multiple sclerosis , 2013, Neurology.

[85]  P. Marrack,et al.  Sexual dimorphism in autoimmunity. , 2015, The Journal of clinical investigation.

[86]  R. Benedict,et al.  Risk factors for and management of cognitive dysfunction in multiple sclerosis , 2011, Nature Reviews Neurology.

[87]  C. Pozzilli,et al.  Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study , 2014, BMC Neurology.

[88]  Yinshan Zhao,et al.  Relapses in multiple sclerosis are age- and time-dependent , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[89]  T. Sørensen,et al.  Childhood body mass index and multiple sclerosis risk: a long-term cohort study , 2013, Multiple sclerosis.

[90]  K. Joseph,et al.  Children of chronically ill parents: Relationship between parental multiple sclerosis and childhood developmental health , 2015, Multiple sclerosis.

[91]  A. Pines Male menopause: is it a real clinical syndrome? , 2011, Climacteric : the journal of the International Menopause Society.

[92]  I. Mackay,et al.  Sexual dimorphism in autoimmune disease. , 2009, Current molecular medicine.

[93]  J. Pakpoor,et al.  Childhood obesity and risk of pediatric multiple sclerosis and clinically isolated syndrome , 2013, Neurology.

[94]  L. Steinman,et al.  Peroxisome proliferator-activated receptor (PPAR)α and -γ regulate IFNγ and IL-17A production by human T cells in a sex-specific way , 2012, Proceedings of the National Academy of Sciences.

[95]  Linda Douw,et al.  Subcortical atrophy and cognition , 2012, Neurology.

[96]  J. Aarseth,et al.  Stoppers and non‐starters of disease‐modifying treatment in multiple sclerosis , 2013, Acta neurologica Scandinavica.

[97]  Pierre Grammond,et al.  Geographical Variations in Sex Ratio Trends over Time in Multiple Sclerosis , 2012, PloS one.

[98]  K. Spach,et al.  Vitamin D3 Confers Protection from Autoimmune Encephalomyelitis Only in Female Mice1 , 2005, The Journal of Immunology.

[99]  L. Kappos,et al.  The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL , 2009, Journal of Neurology.

[100]  R. Marrie,et al.  Change in the Health-Related Quality of Life of Multiple Sclerosis Patients over 5 Years. , 2013, International journal of MS care.

[101]  S. Lydersen,et al.  Anxiety and depression in multiple sclerosis. A comparative population-based study in Nord-Trøndelag County, Norway , 2009, Multiple sclerosis.

[102]  S. Bhasin,et al.  Diagnosis and treatment of hypogonadism in men. , 2011, Best practice & research. Clinical endocrinology & metabolism.

[103]  R. Considine,et al.  Gender differences in serum leptin levels in humans. , 1996, Biochemical and molecular medicine.

[104]  A. Arnold,et al.  A role for sex chromosome complement in the female bias in autoimmune disease , 2008, The Journal of experimental medicine.

[105]  B. Laursen,et al.  Gender effects on treatment response to interferon‐beta in multiple sclerosis , 2014, Acta neurologica Scandinavica.

[106]  M. Goldacre,et al.  Testicular hypofunction and multiple sclerosis risk: A record‐linkage study , 2014, Annals of neurology.

[107]  Ruijie Liu,et al.  Comparing genotyping algorithms for Illumina's Infinium whole-genome SNP BeadChips , 2011, BMC Bioinformatics.

[108]  anonymous,et al.  Comprehensive review , 2019 .

[109]  H. Brønnum-Hansen,et al.  Suicide among Danes with multiple sclerosis , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[110]  C. Caon,et al.  Factors That Influence Adherence and Strategies to Maintain Adherence to Injected Therapies for Patients With Multiple Sclerosis , 2010, The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses.

[111]  Frederik Barkhof,et al.  Gender-related differences in functional connectivity in multiple sclerosis , 2012, Multiple sclerosis.

[112]  K. Yorkston,et al.  Social support, depression, and physical disability: age and diagnostic group effects. , 2014, Disability and health journal.

[113]  A. Kolk,et al.  Sex differences in physical symptoms: the contribution of symptom perception theory. , 1997, Social science & medicine.

[114]  Kurt L. Johnson,et al.  Being in- or out-of-sync: Couples' adaptation to change in multiple sclerosis , 2010, Disability and rehabilitation.

[115]  B. Healy,et al.  Effect of gender on late-onset multiple sclerosis , 2012, Multiple sclerosis.

[116]  G. Knudsen Gender bias in autoimmune diseases X chromosome inactivation in women with multiple sclerosis , 2009, Journal of the Neurological Sciences.

[117]  C. Weissbrod,et al.  Growing up with an ill parent: An examination of family characteristics and parental illness features. , 2015, Families, systems & health : the journal of collaborative family healthcare.

[118]  A. Arnold,et al.  XY sex chromosome complement, compared with XX, in the CNS confers greater neurodegeneration during experimental autoimmune encephalomyelitis , 2014, Proceedings of the National Academy of Sciences.

[119]  Frederik Barkhof,et al.  Sex‐specific extent and severity of white matter damage in multiple sclerosis: Implications for cognitive decline , 2014, Human brain mapping.

[120]  W. Mcdonald Diagnosis of multiple sclerosis. , 1989, BMJ.

[121]  S. Josephson,et al.  The Importance of Lesbian, Gay, Bisexual, and Transgender Health in Neurology: What's in a Name? , 2015, JAMA neurology.

[122]  David H. Miller,et al.  Pregnancy, sex and hormonal factors in multiple sclerosis , 2014, Multiple sclerosis.

[123]  C. Caltagirone,et al.  Gender-related effect of clinical and genetic variables on the cognitive impairment in multiple sclerosis , 2004, Journal of Neurology.

[124]  P. Rieckmann,et al.  The natural history of secondary progressive multiple sclerosis , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[125]  K. Trinkaus,et al.  Phenotype and prognosis in African-Americans with multiple sclerosis: a retrospective chart review , 2006, Multiple sclerosis.

[126]  Yinshan Zhao,et al.  Birth Outcomes in Newborns Fathered by Men with Multiple Sclerosis Exposed to Disease-Modifying Drugs , 2014, CNS Drugs.